Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300 | Zendy

Jian Wei | Zendy; Lina A. Shehadeh | Zendy; James Mitrani | Zendy; Mônica Gomes Pessanha | Zendy; Tatiana I. Slepak | Zendy; Keith A. Webster | Zendy; Nanette H. Bishopric | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300

Author(s) -

Jian Wei,

Lina A. Shehadeh,

James Mitrani,

Mônica Gomes Pessanha,

Tatiana I. Slepak,

Keith A. Webster,

Nanette H. Bishopric

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.760488

Subject(s) - mef2 , pressure overload , histone acetyltransferase , muscle hypertrophy , medicine , gata4 , hdac4 , heart failure , acetylation , acetyltransferase , histone deacetylase 5 , histone deacetylase , ventricular remodeling , endocrinology , histone , transcription factor , microbiology and biotechnology , biology , enhancer , biochemistry , gene , cardiac hypertrophy

Acetyltransferase p300 is essential for cardiac development and is thought to be involved in cardiac myocyte growth through MEF2- and GATA4-dependent transcription. However, the importance of p300 in the modulation of cardiac growth in vivo is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research